본문 바로가기
  • Home

Amendment Proposals for the Act on Decisions on Life-Sustaining Treatment to Improve End-of-Life Care

  • Korean Journal of Medical Ethics
  • Abbr : 의료윤리
  • 2024, 27(2), pp.51-70
  • Publisher : The Korean Society For Medical Ethics
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : March 6, 2024
  • Accepted : June 25, 2024
  • Published : June 30, 2024

Ilhak LEE ORD ID 1 박형욱 2 고윤석 3 Dae Kyun Kim 4 Min Sun Kim 5 KIM Sanghee 6 KIM Claire Junga 7 Kim Cho Hee 8 Jae Young Moon 9 Su Jin Baik 10 seyoung seo 3 송인규 11 Yoo, SangHo 12 Shin Hye Yoo 13 이유정 14 Wonho Choi 15

1연세대학교
2단국대학교 의과대학 인문사회의학교실
3서울아산병원
4가톨릭대학교 인천성모병원 가정의학과
5가톨릭대학교 의과대학 여의도성모병원 안과학교실
6연세대학교 간호대학
7동아대학교 의과대학
8강원대학교
9충남대학교
10(재) 국가생명윤리정책원
11연세대학교 의과대학 소아과학교실
12한양대학교
13서울대학교 의과대학 서울대학교병원 내과
14고려대학교구로병원
15서울대학교병원

Accredited

ABSTRACT

The Act on Hospice and Palliative Care and Decisions on Life-Sustaining Treatment for Patients at the End of Life (ELDA) was passed by the Korean National Assembly in 2016 and came into effect in 2018. Although the stated purpose of the act is to uphold patient autonomy and dignity in the context of end-of-life (EOL) care, its utilization remains low, with only some 40% of EOL decisions reflecting patients’ direct opinions. This study aims to pinpoint areas for enhancing ELDA by comparing it with similar systems in other countries and gathering expert opinions. To achieve this, we reviewed ELDA, compared it with EOL care systems in Taiwan, Japan, the UK, the US, and Germany, and surveyed Korean medical experts to collect their thoughts on how ELDA might be improved. On this basis, we make several recommendations, including broadening the scope of ELDA, bolstering the role of advance directives, and providing education for healthcare professionals. These recommendations are expected to increase the utilization rate of ELDA and enhance the quality of EOL care in South Korea.

Citation status

* References for papers published after 2023 are currently being built.